Novel dual action anti-neoplastic drugs

Elazar Meyer
Additional contact information
Elazar Meyer: Hebrew University, 214 Haalon St., Matta, Israel

Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990, 2022, vol. 3, issue 2, 120-126

Abstract: A novel drug structure (a Markush structure) is presented including molecules that can be effective as dual action drugs namely as inhibitors of epidermal growth factor kinase domain as well as having anti-angiogenic activity. The novel Markush structure includes molecules that might have dual anti-neoplastic activity leading to the development of a novel effective cancer drug for treating e.g., pancreatic cancer.

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://techniumscience.com/index.php/biochemmed/article/view/6972 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tec:bioche:ojs:6972

DOI: 10.47577/biochemmed.v3i2.6972

Access Statistics for this article

Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 is currently edited by Anna Maria Golita

More articles in Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 from Technium Science
Bibliographic data for series maintained by Anna Maria Golita ().